Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
Instituto do Cancer do Estado de São Paulo
Radboud University Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Turning Point Therapeutics, Inc.
Stanford University
Grupo Espanol de Tumores Neuroendocrinos
M.D. Anderson Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Exelixis
Sanofi
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
University Medical Center Groningen
Stanford University
Hoffmann-La Roche
Mayo Clinic
National Cancer Center, Korea
National Cancer Center, Korea
M.D. Anderson Cancer Center
The First Affiliated Hospital of Xiamen University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
West China Hospital
Alliance for Clinical Trials in Oncology
Massachusetts General Hospital
Academic and Community Cancer Research United
University College, London
Radboud University Medical Center
UNICANCER
Dana-Farber Cancer Institute
Hoffmann-La Roche
Instituto do Cancer do Estado de São Paulo
Institut Bergonié
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Fore Biotherapeutics